Streptomyces antiinflammaticus from Rehmannia glutinosa Produces Dual Immunomodulatory Metabolites That Upregulate IL-10 and Inhibit GSK3β/NF-κB
Molecules · 27.10.2026 · 31 (21) · 3869
DOI: 10.3390/molecules31213869 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, online erschienen am 27.10.2026. Verfasst von Tong Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Henan University of Chinese Medicine, Zhengzhou 450046, China. Hauptthemen laut MEDLINE: Glycogen Synthase Kinase 3 beta, Interleukin-10, Streptomyces, NF-kappa B. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Henan Academy of Sciences, National Natural Science Foundation of China, Postdoctoral Foundation of Henan Province.
Abstract (Originalsprache)
Strain RerS4 was isolated from the rhizosphere of the medicinal plant Rehmannia glutinosa and comprehensively identified for its taxonomic status and anti-inflammatory secondary metabolites. Polyphasic taxonomy combined with genome-based analyses, including average nucleotide identity (82.87–85.87%) and digital DNA-DNA hybridization (26.7–31.9%), confirmed that RerS4 represents a novel Streptomyces species, designated Streptomyces antiinflammaticus. Eight fermentation media were screened using an IL-6/TNF-α inhibitory bioassay in A549 and THP-1 cells, and GYM I medium with optimal anti-inflammatory activity was adopted for large-scale fermentation. Five secondary metabolites were purified from the fermentation broth, including one undescribed amide (1), alongside four known compounds (2–5). Bioactivity assays indicated that compounds 1 and 5 inhibited pro-inflammatory cytokine production. Mechanistically, both compounds suppressed the phosphorylation of p65 (Ser536) and GSK3β (Tyr216) in A549 cells. In THP-1 macrophages, compound 1 selectively targeted p65, while compound 5 inhibited both proteins. qPCR results revealed that compound 1 downregulated pro-inflammatory cytokines (IL-1β, IL-6, TNF-α) and upregulated the anti-inflammatory cytokine IL-10, whereas compound 5 reduced IFN-γ mRNA expression in A549 cells. This study demonstrates that Streptomyces antiinflammaticus is a valuable resource for distinctive anti-inflammatory and immunomodulatory natural products.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Henan University of Chinese Medicine, Zhengzhou 450046, China.
- College of Plant Protection, Henan Agricultural University, Zhengzhou 450046, China.
Förderung
- Henan Academy of Sciences
- National Natural Science Foundation of China
- Postdoctoral Foundation of Henan Province
- Kunlun Talent High-end Innovation and Entrepreneurship Talent Leading Talent Project of Qinghai Province
- Henan Province Young Backbone Teacher Training Program for Higher Education Institutions
- Natural Science Foundation of Henan
Zitieren
APA
Wang, T., Liang, Y., Yang, F., Du, Y., Li, J., Du, P., Qin, Y., & He, H. (2026). Streptomyces antiinflammaticus from Rehmannia glutinosa Produces Dual Immunomodulatory Metabolites That Upregulate IL-10 and Inhibit GSK3β/NF-κB. Molecules, 31(21), 3869. https://doi.org/10.3390/molecules31213869
Vancouver
Wang T, Liang Y, Yang F, Du Y, Li J, Du P, et al. Streptomyces antiinflammaticus from Rehmannia glutinosa Produces Dual Immunomodulatory Metabolites That Upregulate IL-10 and Inhibit GSK3β/NF-κB. Molecules. 2026;31(21):3869. doi:10.3390/molecules31213869
BibTeX
@article{Wang2026,
author = {Wang, Tong and Liang, Yu and Yang, Feiyan and Du, Yueqing and Li, Jiaqi and Du, Pengqiang and Qin, Yanqin and He, Hairong},
title = {Streptomyces antiinflammaticus from Rehmannia glutinosa Produces Dual Immunomodulatory Metabolites That Upregulate IL-10 and Inhibit GSK3β/NF-κB},
journal = {Molecules},
year = {2026},
volume = {31},
number = {21},
pages = {3869},
doi = {10.3390/molecules31213869}
}
EUVIMED